“Biolink’s integrated approach prepares New Zealand’s deep-tech projects and companies to land in China with the best chance of success.”
Biolink is a joint venture between Wellington UniVentures and Suzhou New Drug Incubator Life Science Co. Ltd, an incubator of Suzhou Shanghai Institute of Materia Medica. Aimed at supporting New Zealand deep-tech companies wishing to build a presence in China, Biolink works to enhance the flow of technology and partnerships between New Zealand and China, opening up scientific, technological and investment activities between the two countries.
The company was formed in 2018 following the launch of the New Zealand-China (Suzhou) Innovation Centre in Suzhou Industrial Park, a 288 sq km development park designed to encourage innovation and entrepreneurship in high-tech industries—with a particular focus on bio-medicine, nanotechnology, new materials and new-generation information technology.